hmm, could it be so obvious that the "smart money" knew all along that the Fisch patent claims were a joke? LOL!
aren't you the idiot that has been saying RPRX doesn't have the patent rights needed in order to commercialize Androxal? LMFAO!
in that case i'm glad i sold all my shares at $7.96 when you scared me into doing so
TSRO is almost 6 times larger than RPRX and the ownership structure is different. I would imagine the swings would be magnified in RPRX.
the FDA could take 60 days to accept or deny a filing. even if Repros has the papers ready by the end of the year, there will likely be no decision until February
i don't know what all the fuss is about. sure, the filing is good, but the real important matter is if the FDA accepts the filing for review.
can you say zero RELEVANCE? check all small cap experimental biotechnology stocks. no revenue besides interest income. you're a rookie and you need to take a backseat to the grown ups.
you mean to tell me that a few random retail investors aren't responsible for the entire trend in this stock? lol